- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 401/04
Total number of patents in this class: 11996
10-year publication summary
|
839
|
907
|
884
|
901
|
880
|
889
|
848
|
888
|
731
|
394
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4878 |
273 |
| Novartis AG | 10867 |
207 |
| Celgene Corporation | 1412 |
158 |
| Merck Patent GmbH | 5829 |
155 |
| F. Hoffmann-La Roche AG | 7929 |
151 |
| Boehringer Ingelheim International GmbH | 4695 |
136 |
| Hoffmann-La Roche Inc. | 3405 |
115 |
| Vertex Pharmaceuticals Incorporated | 1598 |
115 |
| Janssen Pharmaceutica N.V. | 3399 |
111 |
| BASF SE | 20904 |
110 |
| Takeda Pharmaceutical Company Limited | 2711 |
109 |
| Merck Sharp & Dohme LLC | 3749 |
109 |
| Bayer AG | 3327 |
105 |
| AstraZeneca AB | 2917 |
98 |
| Gilead Sciences, Inc. | 2032 |
90 |
| Pfizer Inc. | 3379 |
89 |
| Syngenta Crop Protection AG | 6052 |
88 |
| FMC Corporation | 845 |
88 |
| Amgen Inc. | 4074 |
86 |
| Sumitomo Chemical Company, Limited | 9040 |
85 |
| Other owners | 9518 |